...
首页> 外文期刊>Sleep >The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study
【24h】

The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study

机译:苯二氮卓受体激动剂的使用和慢性阻塞性肺疾病患者的呼吸衰竭风险:基于全国人群的病例对照研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Study Objectives: Insomnia is prevalent in patients with chronic obstructive pulmonary disease (COPD), and benzodiazepine receptor agonists (BZRAs) are the most commonly used drugs despite their adverse effects on respiratory function. The aim of this study was to investigate whether the use of BZRAs was associated with an increased risk of respiratory failure (RF) in COPD patients.
机译:研究目标:慢性阻塞性肺疾病(COPD)患者普遍存在失眠症,而苯二氮卓受体激动剂(BZRAs)尽管对呼吸功能有不良影响,但也是最常用的药物。这项研究的目的是调查在COPD患者中使用BZRA是否与呼吸衰竭(RF)风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号